Form 8K Delcath Systems Inc For: 12 January
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Delcath Systems Inc (DCTH)
Delcath Systems Inc stock price live, this page displays NASDAQ DCTH stock exchange data. View the DCTH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Delcath Systems Inc real time stock price chart below.
What Is the Delcath Systems Inc Stock Price Today?
The Delcath Systems Inc stock price today is 10.370.
What Is the Stock Symbol for Delcath Systems Inc?
The stock symbol for Delcath Systems Inc is "DCTH."
What Stock Exchange Does Delcath Systems Inc Trade On?
Delcath Systems Inc is listed and trades on the NASDAQ stock exchange.
Is Delcath Systems Inc a Good Stock to Buy?
Determining whether Delcath Systems Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DCTH quote. (ISIN: US24661P8077)
What Is the Delcath Systems Inc Stock Price Today?
The Delcath Systems Inc stock price today is 10.370.
What Is the Stock Symbol for Delcath Systems Inc?
The stock symbol for Delcath Systems Inc is "DCTH."
What Stock Exchange Does Delcath Systems Inc Trade On?
Delcath Systems Inc is listed and trades on the NASDAQ stock exchange.
Is Delcath Systems Inc a Good Stock to Buy?
Determining whether Delcath Systems Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DCTH quote. (ISIN: US24661P8077)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.080
10.645
52 wk Range
8.120
18.230
DCTH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.08010.645
52 wk Range
8.12018.230
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DCTH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
22.333
Upside
+115.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Delcath Systems Inc Company Profile
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.
Delcath Systems Inc Earnings Call Summary for Q3/2025
- Delcath Systems reported Q3 2025 EPS of $0.02 (beating -$0.03 forecast) but missed revenue expectations with $20.6M (vs $23.83M projected), causing shares to drop 8.6% to $8.70.
- Despite revenue shortfall, the company maintained strong 87% gross margins and a solid cash position of $89M with no debt, while net income decreased to $0.8M from $1.9M year-over-year.
- Management reaffirmed 2025 revenue guidance of $83-85M with projected gross margins of 85-87%, expecting continued positive adjusted EBITDA and cash flow.
- Strategic expansion includes increasing sales regions and treatment centers, with CEO Gerard Michel emphasizing HEPZATO's 'substantial potential' for improving outcomes in liver metastases patients.
- Key challenges include market seasonality in treatment scheduling, competition from clinical trials by Replimune and Thomas Jefferson, and pricing pressure from the NDRA program.
Last Updated: 2025-11-04, 09:36 a/m
Read Full TranscriptCompare DCTH to Peers and Sector
Metrics to compare | DCTH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDCTHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 300.4x | −2.9x | −0.6x | |
PEG Ratio | 2.93 | −0.09 | 0.00 | |
Price/Book | 3.1x | 4.5x | 2.6x | |
Price / LTM Sales | 4.5x | 2.9x | 3.4x | |
Upside (Analyst Target) | 107.3% | 50.4% | 39.6% | |
Fair Value Upside | Unlock | 4.1% | 5.2% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 22.333
(+115.36% Upside)
Earnings
Latest Release
Nov 04, 2025
EPS / Forecast
0.02 / -0.03
Revenue / Forecast
20.60M / 23.83M
People Also Watch
FAQ
What Is the Delcath Systems (DCTH) Stock Price Today?
The Delcath Systems stock price today is 10.370
What Stock Exchange Does Delcath Systems Trade On?
Delcath Systems is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Delcath Systems?
The stock symbol for Delcath Systems is "DCTH."
What Is the Delcath Systems Market Cap?
As of today, Delcath Systems market cap is 359.84M.
What Is Delcath Systems's Earnings Per Share (TTM)?
The Delcath Systems EPS (TTM) is 0.03.
When Is the Next Delcath Systems Earnings Date?
Delcath Systems will release its next earnings report on Mar 31, 2026.
From a Technical Analysis Perspective, Is DCTH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Delcath Systems Stock Split?
Delcath Systems has split 5 times.
How Many Employees Does Delcath Systems Have?
Delcath Systems has 96 employees.
What is the current trading status of Delcath Systems (DCTH)?
As of Jan 19, 2026, Delcath Systems (DCTH) is trading at a price of 10.370, with a previous close of 10.210. The stock has fluctuated within a day range of 10.080 to 10.645, while its 52-week range spans from 8.120 to 18.230.
What Is Delcath Systems (DCTH) Price Target According to Analysts?
The average 12-month price target for Delcath Systems is USD22.33333, with a high estimate of USD30 and a low estimate of USD18. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +115.36% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.